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The liver biopsy is a gold standard for diagnosing liver 
steatosis in children and adults. However, in 2012, the Eu-
ropean Society for Pediatric Gastroenterology, Hepatology 
and Nutrition proclaimed that liver biopsy should not be 
used as a screening procedure for children with nonalco-
holic fatty liver disease. Indications for liver biopsy is still 
being discussed, and now there is no enough evidence to 
formulate a list of indications for this procedure in children 
with the primary diagnosis of nonalcoholic fatty liver disease 
(NAFLD), biopsy indication is stronger in the case of dif-
ficulties in carrying out differential diagnosis and in case of 
risk of progression to liver cirrhosis [1].
Non-invasive methods for diagnosing liver steatosis in 
children are important because they can be used to monitor 
the course of the disease for a long period [2]. Non-invasive 
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ultrasound methods for diagnosing steatosis include stan-
dard ultrasound examination, sonographic quantification 
of a hepatorenal index, transient elastography, shear wave 
elastography.
Ultrasound. Ultrasound is the most common imaging 
method used to diagnose liver steatosis. Due to its wide 
availability, economic feasibility and simplicity of usage, 
ultrasound can be used as a liver pathology screening tool. 
A healthy liver parenchyma has a homogeneous echo texture 
and echogenicity similar to the echogenicity of the right kid-
ney. In the case of liver steatosis, the presence of lipid drops 
within hepatocytes violates the propagation of the sound 
wave, causing the scattering and attenuation of ultrasound 
waves. The dispersion of ultrasound waves is manifested in 
the form of a more vivid visualization of liver parenchyma 
compared with the kidneys. The attenuation of ultrasound 
waves also causes loss of signal, which leads to darkening of 
vessels and bile ducts and blurred diaphragm [2]. Distal at-
tenuation of ultrasound is usually typical for steatosis in the 
liver with lesions > 30 % of hepatocytes [1].
Classification of the degree of liver steatosis according to 
ultrasound data:
1. Absence of steatosis (echogenicity of the liver is simi-
lar to the kidney);
2. Slight degree of steatosis (diffusely increased echo-
genicity of the liver);
3. Moderate degree of steatosis (echogenicity of the 
liver reduces imaging of the walls of vessels and diaphragm);
4. Severe degree of steatosis (no imaging of the hepatic 
vessels and diaphragm) [3].
However, ultrasound study has some disadvantages: 
oper ator and machine dependence, as well as the lack of ob-
jective quantitative analysis [1]. Ultrasound has low sensitiv-
ity for the differentiation between healthy liver and early ste-
atosis and other pathological conditions such as fibrosis 
and/or inflammation, which may increase the echogenicity 
of the liver, sometimes can mimic liver steatosis. Therefore, 
an ultrasound evaluation of liver steatosis should be per-
formed taking into account these constraints; the results 
should be carefully interpreted and this procedure should 
not be recommended as the only tool for diagnosing or 
monitoring NAFLD in children.
Hepatorenal index (HI). To calculate this indicator, the 
echogenicity of the liver and kidneys is evaluated in the 
study of the gray scale (value 0–255) using the built-in his-
togram. It is used with the average value of three repetitive 
measurements based on the ratio of the average echogenici-
ty of the liver to the echogenicity of the kidney. A value be-
low 1.0 is considered to be normal. The degree of steatosis is 
considered to be mild (HI 1.05–1.24), moderate (HI 1.25–
1.64) or severe (HI ≥ 1.65). One of the disadvantages of 
 using HI is its variability and dependence on the operator 
and ultrasound apparatus [4].
Assessment of ultrasound attenuation. Quantitative esti-
mation of the echo signal intensity can be used to objecti-
vize the diagnosis of steatosis. There are methods for evalu-
ating the parameters of the images in B-mode or analysis of 
the signal backscatter ultrasound waves [5]. Several studies 
have found an increase in liver attenuation coefficients and 
backscattering designed by ultrasound in patients compared 
with healthy persons [6]. However, most studies have been 
focused on differentiation of pathological and altered liver 
and did not estimate the severity of the NAFLD.
The attenuation coefficient represents the summation of 
ultrasound energy losses due to the echo reflection, scatter-
ing, and absorption. Studies showed that scattering has only 
a very small contribution to the attenuation coefficient in 
normal liver, but the dispersion of fat drops significantly af-
fects the attenuation of US. In addition, studies of Kanaya-
ma et al. have shown that the number of lipid drops and their 
size in the liver tissues can greatly contribute to energy ab-
sorption in the spread of ultrasound [6].
Elastography. Ultrasound elastography is now increasing-
ly used in the diagnosing diffuse liver disease. This  method 
provides the possibility of differentiation between simple 
steatosis and nonalcoholic steatohepatitis that has signs of 
inflammation and fibrosis [2]. There are several methods for 
ultrasound elastography, including transient elastography, 
shear wave elastography (SWE) and acoustic radiation force 
impulse elastography (ARFI).
Transient elastography. Transient elastography (Fibro-
Scan 502 Touch) is a new non-invasive method for diagnos-
ing fibrosis and most recently, due to the equipment of the 
apparatus with a new function, for the diagnosing steatosis as 
well [7]. Measuring the degree of steatosis is based on lipids 
ability to impact the spread of ultrasound. The calculation 
of the indicator characterizing steatosis degree — the con-
trolled attenuation parameter (CAP) — is due to the com-
plicated process of ultrasound attenuation with its reverse 
propagation at an average frequency of 3.5 MHz [8]. CAP is 
an effective parameter for the determination of even low de-
gree of steatosis. The study of V. de Lédinghen et al. showed 
that CAP significantly correlated with SteatoTest and the fat 
content of the liver, which was determined from the mor-
phological study [9]. A 2014 meta-analysis by the Chinese 
scientists for the diagnostic accuracy of CAP to determine 
the degree of liver steatosis in various diseases has revealed 
that CAP has high sensitivity and specificity for determining 
the presence of liver steatosis, but is limited to precisely de-
termining the degree of steatohepatitis that somewhat limits 
its wide application in clinical practice [10]. A recent study 
conducted in a small cohort of children who had a liver 
biopsy according to clinical indications identified a limit 
of 225 dB/m for predicting steatosis, 0.87 sensitivity, 0.83 
specificity and AUROC 0.93 [11].
Therefore, transient elastography with FibroScan is 
a sufficiently sensitive method for non-invasive diagnosis 
of steatosis, which can be used for primary diagnosis and 
moni toring of the effectiveness of treatment in children.
Shear wave elastography. The basis of SWE lies in the 
property of the ultrasound to excite the mechanical shear 
wave transverse to its direction. The velocity of propaga-
tion of these waves depends on tissue rigidity or viscoelastic 
properties [12]. The real-time SWE has some advantages 
over TE. First, this function is integrated in the usual ultra-
sound apparatus, and therefore, can use the real-time image 
in the B-mode to assess morphological changes or to detect 
of focal lesions of the liver. Advantage of SWE, as well as 
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ARFI, is to provide a quantitative map of liver tissue stiffness 
in real time. The spatial heterogeneity of the liver stiffness 
can be visualized, and the area of interest used for measure-
ment can be corrected. The area of interest for liver stiffness 
measurements can be adjusted in size and location to avoid 
such artifacts as those occurring near large pulsating vessels 
[13].
The purpose of our work is to compare the possibilities 
of diagnosing steatosis and liver fibrosis by using standard 
ultrasound study, SWE with steatometry and transient elas-
tography using the CAP function.
Materials and methods
The survey included 90 patients aged 5 to 17 years: 
boys — 54 (60 %), girls — 36 (40 %). The average age of 
patients was (12.08 ± 2.71) years. The assessment of BMI 
was carried out according to the WHO recommendations 
(gender and age specific) [14].
Determination of the presence and degree of liver ste-
atosis was carried out with FibroScan 502 Touch (Echosens, 
France) with CAP measurement (Table 1) [15]. An M-
sensor with an ultrasonic frequency of 3.5 MHz was used. 
Also we determined the changes in elasticity or stiffness of 
the liver (LSM) which indicates the development of fibro-
sis, and the CAP, which corresponds to steatosis degree. The 
liver stiffness was evaluated in kilopascals (kPa), viscosity or 
steatosis — in decibels per meter (dB/m).
The obtained parameters of liver stiffness were evalu-
ated as follows: elastometric parameters up to 5.9 kPa corre-
sponded to the stage of fibrosis F0; 6–7.0 kPa corresponded 
to the stage of fibrosis F1, from 7.1 to 8.7 kPa — stage F2, 
over 8.7 kPa — F3 on Metavir score [16].
Also ultrasound examination of the liver parenchyma by 
the B-method with simultaneous shear wave elastography 
and steatometry on the Ultima Expert (Radmir, Kharkiv) 
with a cone-shaped sensor at frequencies of 2–5 MHz at a 
depth of 10–50 mm from the capsule was performed. The 
number of successful measurements should have been at 
least 3. Then, from the indicated measurements, the me-
dian characterizing the liver stiffness in kilopascals as well 
as the average coefficient of ultrasound attenuation (UAC) 
(dB/m) were determined.
Depending on steatosis presence, determined on the 
basis of CAP, and presence of overweight and obesity the 
patients were divided into 3 groups: the 1st group consisted 
of 45 patients with liver steatosis and overweight/obesity 
(50.0 %), the 2nd group included 35 patients with excessive 
weight and obesity without steatosis (38.9 %), the 3rd group 
(control group) consisted of 10 patients with normal weight 
without steatosis (11.1 %). The exclusion criteria were the 
presence of secondary causes of steatosis (viral, autoim-




Average values of the size of the liver and gallbladder are 
given in Table 2.
The largest liver size was observed in the 1st group of pa-
tients (p < 0.01). A detailed analysis of these parameters, 
depending on the growth of a child, also showed that almost 
all (88.9 %) of the children in the 1st group experienced an 
increased size of the liver due to all the lobes.
The echogenicity of the liver was increased in 3/4 of the 
patients with overweight/obesity (73.7 % in the 1st group 
patients and 61.1 % in the 2nd group). For the analysis of 
structural changes in the liver, the following characteristics 
of the parenchyma were assessed: granularity, echogenicity, 
and distal attenuation of ultrasound. Specific for patients 
with steatosis was granular structure of the liver, which was 
observed in 36 patients (80.0 %).
In children of the 1st group the changed structure of the 
liver parenchyma was detected 2.2 times more frequently 
than in the 2nd and 3rd groups (37.1 and 30.0 %, respectively) 
(Fig. 1).
In the majority of the 1st group patients elevated and 
uneven liver echogenicity was observed (75.6 and 71.1 %, 
respectively). Distal ultrasound attenuation was detected 2 
times more frequently in this group than in the 2nd group 
children.




Up to 232 dB/m S0 Less than 10 %
233–255 dB/m S1 11–33 %
256–289 dB/m S2 34–66 %
Above 290 dB/m S3 67–100 %








Liver right lobe, mm 127.49 ± 1.77 133.38 ± 2.39** 122.57 ± 2.88 118.20 ± 2.77
Liver left lobe, mm 58.62 ± 1.01 61.64 ± 1.69* 56.03 ± 1.00 54.10 ± 2.22
Gallbladder volume, mm3 27.08 ± 0.80 29.71 ± 1.25* 25.66 ± 0.93 20.20 ± 1.56
Notes: * — p < 0.05 — significance of differences between indicators in children of the 1st and 3rd groups; ** — 
p < 0.01 — the significance of the differences between indicators in children of the 1st and 2nd groups.
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It should be noted that in children with steatosis imaging 
of the hepatic veins significantly worsened: in the 1st group 
children hepatic veins imaging deterioration was observed 2 
times more often than in the 2nd group.
Data of transient elastography
The parameters of liver parenchyma stiffness and CAP 
in children with obesity and overweight according to tran-
sient elastography data are given in Table 3.
The liver stiffness in the examined patients varied from 
2.3 to 8.8 kPa, and the CAP index — from 108 to 349 dB/m. 
In the overwhelming majority (96.1 %) of patients, fibrosis 
was absent; the first and second degree of fibrosis was regis-
tered only in 3 patients (3.9 %) in the 1st group.
As can be seen from the data in Table 3, liver stiffness 
rates, although not exceeding the norm, were significantly 
increased in children with steatosis.
Among the patients with steatosis 45.2 % had the first 
stage (up to 33 % of hepatocytes contained fat) and 16.7 % 
had the third stage of fatty degeneration — almost all hepa-
tocytes had fat inclusion (Fig. 2).
Data of shear wave elastography and steatometry
Taking into account liver structural changes, SWE of the 
liver was performed to evaluate the stiffness of the paren-
chyma in the examined children. The average values of liver 
stiffness are given in Table 4.
When comparing liver parenchyma stiffness in groups, a 
significant increase in this parameter in obese children was 
established in comparison with the control group. In chil-
dren with steatosis, higher stiffness rates (although not ex-
ceeding normal) were observed compared to children with 
simple obesity without fatty liver (p < 0.05).
According to liver steatometry findings, the average coef-
ficient of ultrasound attenuation in the 1st group children was 
significantly higher compared to the control group (Table 5).
Comparison of SWE and TE data
When comparing SWE with TE (FibroScan) according 
to contingency table (Table 6) a match in fibrosis detection 
in 47 of the 76 surveyed (presence of fibrosis in 5 children out 
of 6 children and lack in 42 patients out of 70) was found, 
which corresponds to 61.8% diagnostic efficiency.






LSM, kPa 4.6 ± 1.3# 3.9 ± 1.4 4.04 ± 0.6
CAP, dВ/m 266.0 ± 26.8* 193.2 ± 29.9** 167.1 ± 37.2
Notes: # — p < 0.02 — significance of differences between the 1st and 2nd groups; * — p < 0.0001 — the significance 
of the differences between the 1st and 3rd groups; ** — p < 0.05 — significance of differences between the 2nd and 
3rd groups.








Liver stiffness, kPa 5.58 ± 0.17 6.10 ± 0.28* 5.05 ± 0.17** 5.05 ± 0.24
Liver stiffness, m/s 1.34 ± 0.02 1.40 ± 0.03* 1.28 ± 0.02** 1.25 ± 0.03
Notes: * — p < 0.05 — significance of differences between the 1st and 3rd group children; ** — p < 0.05 — signifi-
cance of differences between the 1st and 2nd groups children.
 Normal    Low   Increased 
Figure 2 — Distribution of the 1st group patients 
by steatosis degree
Figure 1 — Frequency of liver parenchyma 
echogenicity changes in children






















1st group 2nd group 3rd group
5.7
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SWE sensitivity for liver fibrosis detection compared 
with transient elastography was 83.33 %, specificity — 
60.0 %, positive predictive value — 15.15 %, negative pre-
dictive value — 97.67 % (Table 7).
When comparing the steatometry findings and CAP in 
the diagnosis of liver steatosis in children the coincidence 
was found in 15 out of 26 cases (steatosis in 14 out of 23 and 
steatosis absence in 1 patient out of 3), which corresponds to 
57.7% diagnostic efficacy (Table 8). 
The steatometry sensitivity for liver steatosis detection 
was 60.87 %, the specificity was 33.33 %, the positive pre-
dictive value was 87.50 %, and the negative predictive value 
was 10.00 % (Table 9). 
Discussion
Thus, the sonographic signs of fatty liver in obese/over-
weight children were a significant elevation in the liver size, 
which was accompanied by increasing the liver parenchy-








UAC, dB/m 1.98 ± 0.03 2.06 ± 0.05* 1.98 ± 0.05** 1.75 ± 0.04
Notes: * — p < 0.05 — significance of differences between the 1st and 3rd groups; ** — p < 0.05 — significance of 
differences between the 2nd and 3rd groups.





Fibrosis (n = 6) 5 1 6
Absence of fibrosis (n = 70) 28 42 70
Total 33 43 76
Table 7 — SWE sensitivity, specificity and predictive values for the liver fibrosis detection
Indicator Value 95% confidence interval
Sensitivity, % 83.33 35.88 to 99.58
Specificity, % 60.00 47.59 to 71.53
Positive coefficient of likelihood 2.08 1.32 to 3.30
Negative coefficient of likelihood 0.28 0.05 to 1.68
Prevalence of the disease, % 7.89 2.95 to 16.40
Positive predictive value, % 15.15 5.11 to 31.90
Negative predictive value, % 97.67 87.71 to 99.94





Steatosis (n = 23) 14 9 23
Absence of steatosis (n = 3) 2 1 3
Total 16 10 26
Table 9 — SWE sensitivity, specificity and predictive values for the liver steatosis detection
Indicator Value 95% confidence interval
Sensitivity, % 60.87 38.54 to 80.29 
Specificity, % 33.33 0.84 to 90.57 
Positive coefficient of likelihood 0.91 0.38 to 2.17
Negative coefficient of likelihood 1.17 0.22 to 6.30
Prevalence of the disease, % 88.46 69.85 to 97.55 
Positive predictive value, % 87.50 61.65 to 98.45 
Negative predictive value, % 10.00 0.25 to 44.50 
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ma echogenicity in 75.6 % (p < 0.05) of cases, changes in 
the liver granularity (80.0 %), by increasing the length of 
the spleen. The liver size increasing and liver parenchyma 
structure alteration (changes in contours and granularity, 
increased echogenicity) were also found more frequently in 
patients with fatty liver.
The liver steatosis according to TE was detected in 22 
children (44.4 %) with no evidence of steatosis in standard 
ultrasound study. These data indicate that CAP can diag-
nose early stages of liver steatosis.
It should be noted that the use of TE has some limita-
tions. Thus, the presence of ascites excludes the possibi-
lity to carry out transient elastography, i.e. elastic waves are 
not able to pass through the liquid; the presence of morbid 
obesity with BMI > 30 kg/m2 requires the use of XL sensor, 
the use of M sensor in such patients is associated with high 
variability of values and the impossibility of obtaining an 
average CAP. LSM is also limited by a number of factors: 
the presence of acute hepatitis is accompanied by changes 
in liver parenchyma, which can lead to an increase in LSM 
levels; the presence of chronic hepatitis with ALT level > 5 
UNL is accompanied by a re-assessment of fibrosis stage; 
the presence of extra-hepatic cholestasis is also accompa-
nied by an increase in liver stiffness, and the presence of 
narrow intercostal spaces may reduce the possibility of the 
method [17].
Taking into account these limitations, an algorithm for 
interpreting the data of transient elastography for the diag-
nosing liver fibrosis in adult patients was offered (by Chan in 
the Wong modification) (Fig. 3) [18].
However, we want to focus attention on the fact that 
transient elastography is one of the most valid non-invasive 
diagnostic methods for liver steatosis and fibrosis detection, 
characterized by high reproducibility, high sensitivity and 
specificity in the diagnosis of cirrhosis. The unconditional 
benefits are painlessness, short duration of the examination, 
which makes TE almost an ideal method for liver pathology 
screening in the general population.
In our study children with fatty liver showed higher 
LSM values compared with children without steatosis on 
0.7 kPa. Although this profile was not clinically relevant, 
since in most patients the liver stiffness remained within 
the normal range, we would like to emphasize that signs of 
liver fibrosis were observed in a small percentage of chil-
dren with liver steatosis and any child without it. This con-
clusion confirms that liver steatosis is not always a benign 
condition; therefore, measures should be taken to evaluate 
the disease at an early stage.
It should be noted that according to Tokuhara et al. 
study, TE was performed in 139 healthy children aged 1 
to 18 years, the setting of LSM was proportional to age 
(which is probably due to physiological changes in the 
liver connective tissue in children and adolescents), while 
the CAP value did not distinguish in children of different 
age groups, which testifies to the absence of age-related 
 changes in the lipids distribution in the parenchyma of 
healthy liver [19].
Concerning the SWE, studies conducted in adults have 
shown that early stages of fibrosis are difficult to detect by 
elastographic imaging: measurements obtained in early fi-
brosis are similar to those obtained in healthy patients [20]. 
The literature data on the influence of steatosis on the elas-
tography values revealed contradictory results. Marginean 
et al. [21] found that the liver stiffness values according to 
ARFI in children with steatohepatitis were significantly 
higher than in the control group, suggesting that liver ste-
atosis leads to increase in the liver parenchyma stiffness. 
Instead, Wong et al. [22] report that liver steatosis does not 
impact the degree of liver fibrosis.
In our study, the liver stiffness was higher in children 
with NAFLD. It should be noted that high elastographic 
values can be mistakenly considered as severe liver fibro-
sis, but the influence of steatosis on the stiffness cannot be 
ruled out.
According to Garkovich et al. [23], providing SWE in 
68 children with steatohepatitis a strong correlation be-
tween liver stiffness and morphological stages of liver ste-
atosis was established. However, there was no association 
between the liver stiffness parameters and the morphologi-
cal features of steatosis and necro-inflammation. Relevant 
data demonstrate the importance of SWE combination 
with liver steatometry.
Our research demonstrated satisfactory diagnostic effi-
cacy of SWE and steatometry in comparison with transient 
elastography and CAP function when diagnosing liver fi-
brosis and steatosis.
Conclusions
Thus, the combination of ultrasound regimes with 
shear wave elastography and steatometry in the context of 
multiparameter ultrasound examination for assessing liver 
structural changes allows evaluating the stage of fibrosis 
and the degree of steatosis in children with diffuse changes 
in liver parenchyma.
So, transient elastography allows accurately assessing 
the degree of fat accumulation in the liver parenchyma 











Exclude liver fibrosis 
(93% sensitivity)




Diagnose liver fibrosis 
(100% sensitivity)
Diagnose liver fibrosis 
(100% sensitivity)
Figure 3 — Algorithm for liver fibrosis assessing 
according to LSM and ALT 
(by Chan in the Wong modification) [18]
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However, a standard ultrasound study maintains the posi-
tion as it can exclude hepatic masses, cysts, or gallblad-
der pathology but according to NASPGHAN guideline 
(2017) a normal hepatic ultrasound cannot exclude the 
presence of NAFLD and therefore is not useful for the 
diagnosis or follow-up [24].
Conflicts of interests. Authors declare no conflicts of in-
terests that might be construed to influence the results or 
interpretation of their manuscript.
References
 1. Vajro P, Lenta S, Socha P, et al. Diagnosis of nonalcoholic 
fatty liver disease in children and adolescents: position paper of the 
ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 
2012 May;54(5):700-13. doi: 10.1097/MPG.0b013e318252a13f.
 2. Di Martino M, Koryukova K, Bezzi M, Catalano C. Im-
aging Features of Non-Alcoholic Fatty Liver Disease in Children 
and Adolescents. Children (Basel). 2017 Aug 11;4(8). pii: E73. doi: 
10.3390/children4080073.
 3. Awai HI, Newton KP, Sirlin CB, Behling C, Schwimmer 
JB. Evidence and recommendations for imaging liver fat in chil-
dren, based on systematic review. Clin Gastroenterol Hepatol. 2014 
May;12(5):765-73. doi: 10.1016/j.cgh.2013.09.050. 
 4. Isaksen VT, Larsen MA, Goll R, Florholmen JR, Paulssen 
EJ. Hepatic steatosis, detected by hepatorenal index in ultrasonogra-
phy, as a predictor of insulin resistance in obese subjects. BMC Obes. 
2016 Sep 20;3:39. doi: 10.1186/s40608-016-0118-0.
 5. Liao YY, Yang KC, Lee MJ, Huang KC, Chen JD, Yeh CK. 
Multifeature analysis of an ultrasound quantitative diagnostic index 
for classifying nonalcoholic fatty liver disease. Sci Rep. 2016 Oct 
13;6:35083. doi: 10.1038/srep35083.
 6. Kanayama Y, Kamiyama N, Maruyama K, Sumino Y. Real-
time ultrasound attenuation imaging of diffuse fatty liver disease. Ul-
trasound Med Biol. 2013 Apr;39(4):692-705. doi: 10.1016/j.ultra-
smedbio.2012.10.021. 
 7. Goldschmidt I, Streckenbach C, Dingemann C, et al. Ap-
plication and limitations of transient liver elastography in children. J 
Pediatr Gastroenterol Nutr. 2013 Jul;57(1):109-13. doi: 10.1097/
MPG.0b013e31829206a0.
 8. Sasso M, Beaugrand M, de Ledinghen V, et al. Controlled 
attenuation parameter (CAP): a novel VCTE™ guided ultrasonic 
attenuation measurement for the evaluation of hepatic steatosis: 
preliminary study and validation in a cohort of patients with chron-
ic liver disease from various causes. Ultrasound Med Biol. 2010 
Nov;36(11):1825-35. doi: 10.1016/j.ultrasmedbio.2010.07.005. 
 9. de Lédinghen V, Vergniol J, Foucher J, Merrouche W, le 
Bail B. Non‐invasive diagnosis of liver steatosis using controlled 
attenuation parameter (CAP) and transient elastography. Liver Int. 
2012 Jul;32(6):911-8. doi: 10.1111/j.1478-3231.2012.02820.x.
 10. Shi KQ, Tang JZ, Zhu XL, et al. Controlled attenuation pa-
rameter for the detection of steatosis severity in chronic liver disease: 
A meta‐analysis of diagnostic accuracy. J Gastroenterol Hepatol. 
2014 Jun;29(6):1149-58. doi: 10.1111/jgh.12519.
 11. Desai NK, Harney S, Raza R, et al. Comparison of con-
trolled attenuation parameter and liver biopsy to assess hepatic ste-
atosis in pediatric patients. J Pediatr. 2016 Jun;173:160-164.e1. doi: 
10.1016/j.jpeds.2016.03.021. 
 12. Dynnyk OB, Mykhalchishin GP, Kobyliak NM, Bodnar 
PM. Liver Stiffness According to Data of Shear Wave Elastography 
in Patients with Diabetes Mellitus Type 2 and Nonalcoholic Fatty 
Liver Disease Depending on Activity of NAFLD. Gastroenterologia. 
2014;(53):24-29. (in Ukrainian).
 13. Tutar O1, Beşer ÖF, Adaletli I, et al. Shear wave elas-
tography in the evaluation of liver fibrosis in children. J Pedi-
atr Gastroenterol Nutr. 2014 Jun;58(6):750-5. doi: 10.1097/
MPG.0000000000000329.
 14. World Health Organization. Growth reference 5-19 years: 
BMI-for-age (5-19 years).  Available from: http://www.who.int/
growthref/who2007_bmi_for_age/en/.
 15. Masaki K, Takaki S, Hyogo H, et al. Utility of controlled 
attenuation parameter measurement for assessing liver steatosis 
in Japanese patients with chronic liver disease. Hepatol Res. 2013 
Nov;43(11):1182-9. doi: 10.1111/hepr.12094.
 16. Degos F, Perez P, Roche B, et al. Diagnostic accuracy of Fi-
broScan and comparison to liver fibrosis biomarkers in chronic viral 
hepatitis: a multicenter prospective study (the FIBROSTIC study). J 
Hepatol. 2010 Dec;53(6):1013-21. doi: 10.1016/j.jhep.2010.05.035.
 17. Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, 
Milic S. Transient elastography (FibroScan®) with controlled at-
tenuation parameter in the assessment of liver steatosis and fibro-
sis in patients with nonalcoholic fatty liver disease - Where do we 
stand? World J Gastroenterol. 2016 Aug 28;22(32):7236-51. doi: 
10.3748/wjg.v22.i32.7236. 
 18. Chan HL, Wong GL, Choi PC, et al. Alanine amino-
transferase‐based algorithms of liver stiffness measurement by 
transient elastography (Fibroscan) for liver fibrosis in chronic hep-
atitis B. J Viral Hepat. 2009 Jan;16(1):36-44. doi: 10.1111/j.1365-
2893.2008.01037.x. 
 19. Tokuhara D, Cho Y, Shintaku H. Transient Elastography-
Based Liver Stiffness Age-Dependently Increases in Children. PLoS 
One. 2016 Nov 18;11(11):e0166683. doi: 10.1371/journal.
pone.0166683.
 20. Yoneda M, Suzuki K, Kato S, et al. Nonalcoholic fatty liver 
disease: US based acoustic radiation force impulse elastography. Ra-
diology. 2010 Aug;256(2):640-7. doi: 10.1148/radiol.10091662. 
 21. Marginean CO, Marginean C. Elastographic assessment of 
liver fibrosisin children: a prospective single center experience. Eur 
J Radiol. 2012 Aug;81(8):e870-4. doi: 10.1016/j.ejrad.2012.04.014.
 22. Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis 
and cirrhosis using liver stiffness measurement in nonalcoholic fatty 
liverdisease. Hepatology. 2010 Feb;51(2):454-62. doi: 10.1002/
hep.23312.
 23. Garcovich M, Veraldi S, Di Stasio E, et al. Liver stiffness 
in pediatric patients with fatty liver disease: diagnostic accuracy 
and reproducibility of shear-wave elastography. Radiology. 2017 
Jun;283(3):820-827. doi: 10.1148/radiol.2016161002.
 24. Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN Clini-
cal Practice Guideline for the Diagnosis and Treatment of Nonal-
coholic Fatty Liver Disease in Children: Recommendations from the 
Expert Committee on NAFLD (ECON) and the North American Soci-
ety of Pediatric Gastroenterology, Hepatology and Nutrition (NASP-
GHAN). J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):319-334. doi: 
10.1097/MPG.0000000000001482.
Received	 12.06.2018	
Vol 52, No 3, 2018142 Gastroenterologia, ISSN 2308-2097 (print), ISSN 2518-7880 (online)
Гастроентерологічні захворювання у дітей / Gastroenterological Diseases in Children
Степанов Ю.М., Завгородня Н.Ю., Лук’яненко О.Ю., Ягмур В.Б., Коненко І.С., Петішко О.П.
Державна установа «Інститут гастроентерології Національної академії медичних наук України», м. Дніпро, Україна
Сонологічні методи діагностики стеатозу 
та фіброзу печінки в дітей
Резюме. Актуальність. Ультразвукове дослідження є най-
більш поширеним методом візуалізації, що використовуєть-
ся для діагностики стеатозу печінки. Метою нашої роботи 
є порівняння можливостей діагностики стеатозу й фіброзу 
печінки за допомогою стандартного ультразвукового дослі-
дження, зсувнохвильової еластографії зі стеатометрією та 
транзієнтною еластографією з визначенням САР. Матеріали 
та методи. В обстеження включено 90 пацієнтів віком від 
5 до 17 років, середній вік пацієнтів становив (12,08 ± 2,71) 
року. Визначення наявності й ступеня стеатозу печінки про-
водилось за допомогою апарата FibroScan 502 Touch F60156 
(Echosens, Франція) з дослідженням САР. Усім дітям про-
водилось ультразвукове дослідження паренхіми печінки 
В-методом з одночасною зсувнохвильовою еластографією й 
стеатометрією на апараті Ultima PA («Радмір», Харків). За-
лежно від наявності стеатозу, що визначався за показником 
САР, й надмірної ваги й ожиріння пацієнти були розподіле-
ні на 3 групи: 1 групу становили 45 пацієнтів зі стеатозом 
печінки й надмірною вагою та ожирінням (50,0  %), 2 гру-
пу — 35 пацієнтів із надмірною вагою та ожирінням без сте-
атозу (38,9  %), 3 групу (група контролю) — 10 пацієнтів із 
нормальною вагою без стеатозу (11,1  %). Результати. Для 
хворих зі стеатозом було характерним підвищення ехоген-
ності печінки (75,0  % пацієнтів). У дітей 1 групи в 2,2 раза 
частіше спостерігалась змінена структура паренхіми печінки 
порівняно з показниками дітей 2 і 3 груп. Жорсткість тка-
нини печінки в обстежених хворих коливалась від 2,3 до 
8,8 кПа, а показник САР — від 108 до 349 дБ/м. У переважної 
більшості (96,1 %) пацієнтів фіброз був відсутнім; перший 
та другий ступінь фіброзу реєструвався лише в 3 пацієнтів 
(3,9 %) першої групи. За даними стеатометрії печінки середні 
показники коефіцієнта затухання ультразвуку в дітей 1 гру-
пи були вірогідно вищими порівняно з контрольною групою 
(p < 0,05). Чутливість методу зсувнохвильової еластографії 
щодо виявлення фіброзу печінки порівняно з транзієнтною 
еластографією становила 83,33 %, специфічність — 60,0 %, 
позитивна прогностична цінність — 15,15 %, негативна 
прогностична цінність — 97,67 %. При порівнянні методів 
стеатометрії та САР-функції транзієнтної еластографії в діа-
гностиці стеатозу печінки в дітей 1 групи було виявлено збіг 
у 15 з 26 випадків, що відповідає діагностичній ефективності 
57,7 %. Висновки. Таким чином, поєднання ультразвукових 
режимів оцінки структурних змін печінки із зсувнохвильо-
вою еластографією та стеатометрією дає можливість оцінити 
стадію фіброзу й ступінь стеатозу в контексті мультипараме-
тричного ультразвукового дослідження в дітей із дифузними 
змінами паренхіми печінки.
Ключові слова: ультразвук; зсувнохвильова еластографія зі 
стеатометрією; транзієнтна еластографія з САР-функцією; 
стеатоз печінки; фіброз печінки
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Резюме. Актуальность. Ультразвуковое исследование яв-
ляется наиболее распространенным методом визуализации, 
используемым для диагностики стеатоза печени. Целью на-
шей работы является сравнение возможности диагностики 
стеатоза и фиброза печени с помощью стандартного ультраз-
вукового исследования, сдвиговолновой эластографии со 
стеатометрией, транзиентной эластографии с использовани-
ем САР-функции. Материалы и методы. Обследовано 90 па-
циентов в возрасте от 5 до 17 лет, средний возраст пациентов 
составил (12,08 ± 2,71) года. Определение наличия и степени 
стеатоза печени проводилось с помощью аппарата FibroScan 
502 Touch F60156 (Echosens, Франция) с исследованием САР. 
Всем детям проводилось ультразвуковое исследование парен-
химы печени В-методом с одновременной сдвиговолновой 
эласто графией и стеатометрией на аппарате Ultima PA («Рад-
мир», Харьков). В зависимости от наличия стеатоза, который 
определялся по показателю САР, и избыточного веса и ожи-
рения пациенты были разделены на 3 группы: 1 группу соста-
вили 45 пациентов со стеатозом печени и избыточным весом/
ожирением (50,0 %), 2 группу — 35 пациентов с избыточным 
весом/ожирением без стеатоза (38,9 %), 3 группу (группа 
контроля) — 10 пациентов с нормальным весом без стеатоза 
(11,1 %). Результаты. Для пациентов со стеатозом было ха-
рактерно повышение эхогенности печени (75,0 % пациен-
тов). У детей 1 группы в 2,2 раза чаще наблюдалось изменение 
структуры паренхимы печени по сравнению с показателями 
2 и 3 групп. Жесткость ткани печени у обследованных боль-
ных колебалась от 2,3 до 8,8 кПа, а показатель САР — от 108 
до 349 дБ/м. У подавляющего большинства (96,1 %) пациен-
тов фиброз отсутствовал; первая и вторая степень фиброза 
была зарегистрирована только у 3 пациентов (3,9 %) первой 
группы. По данным стеатометрии печени средние показатели 
коэффициента затухания ультразвука у детей 1 группы были 
достоверно более высокими по сравнению с контрольной 
группой (p < 0,05). Чувствительность метода сдвиговолновой 
эластографии относительно выявления фиброза печени по 
сравнению с транзиентной эластографией составила 83,33 %, 
специфичность — 60,0 %, положительная прогностическая 
ценность — 15,15 %, отрицательная прогностическая цен-
ность — 97,67 %. При сравнении методов стеатометрии и 
САР-функции транзиентной эластографии в диагностике сте-
атоза печени у детей 1 группы было обнаружено совпадение 
в 15 из 26 случаев, что соответствует диагностической эффек-
тивности 57,7 %. Выводы. Таким образом, сочетание ультра-
звуковых режимов оценки структурных изменений печени со 
сдвиговолновой эластографией и стеатометрией дает возмож-
ность оценить стадию фиброза и степень стеатоза в контексте 
мультипараметричного ультразвукового исследования у детей 
с диффузными изменениями паренхимы печени.
Ключевые слова: ультразвук; сдвиговолновая эластография 
со стеатометрией; транзиентная эластография с САР-фун-
кцией; стеатоз печени; фиброз печени
